Detail

Keywords

Oncology; Surgical Procedures, Minimally Invasive; Urology

Research interests

David D'Andrea is associate professor at the Department of Urology at the Medical University of Vienna. He earned his medical degree from the University-Medical-Center of the Johannes Gutenberg University Mainz (Germany) in 2015 and completed his urology residency at the Medical University of Vienna, achieving certification from the European Board of Urology (F.E.B.U).

Dr. D'Andrea stands out with his profound expertise in urologic oncology, where his primary focus is on cutting-edge translational research and minimally invasive surgery, particularly in the realm of bladder cancer. His remarkable abilities and groundbreaking contributions have earned him recognition as a leading authority in these fields.

He is not only a practitioner but also a highly respected scholar. He serves as an active member of prestigious academic societies and holds key roles as journal and grant reviewer for numerous esteemed national and international organizations. His academic footprint is substantial, having authored over 200 peer-reviewed research papers, boasting an impressive h-index of 30, and accumulating over 3149 citations. He's unwavering commitment to advancing urology has garnered him numerous distinguished awards on both national and international levels.

He is currently a member of several influential collaborative multicenter groups, including the EAU Young Academic Urologists Working Group Urothelial

Selected publications

1. D'Andrea, D. et al., 2017. Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Primary Non-muscle-invasive Bladder Cancer. Clinical Genitourinary Cancer. Available at: http://dx.doi.org/10.1016/j.clgc.2017.03.007.
2. D'Andrea, D. et al., 2017. Lymphocyte-to-monocyte ratio and neutrophil-to-lymphocyte ratio as biomarkers for predicting lymph node metastasis and survival in patients treated with radical cystectomy. Journal of Surgical Oncology, 115(4), pp.455-461. Available at: http://dx.doi.org/10.1002/jso.24521.
3. Moschini, M. & D'Andrea, D. et al., 2017. Characteristics and clinical significance of histological variants of bladder cancer. Nature Reviews Urology, 14(11), pp.651-668. Available at: http://dx.doi.org/10.1038/nrurol.2017.125.
4. D’Andrea, D. et al. (2023) ‘En Bloc Versus Conventional Resection of Primary Bladder Tumor (eBLOC): A Prospective, Multicenter, Open-label, Phase 3 Randomized Controlled Trial’, European Urology Oncology [Preprint]. Available at: http://dx.doi.org/10.1016/j.euo.2023.07.010.
5. D’Andrea, D. et al. (2022) ‘Identifying the Optimal Number of Neoadjuvant Chemotherapy Cycles in Patients with Muscle Invasive Bladder Cancer’, Journal of Urology, 207(1), pp. 70–76. Available at: http://dx.doi.org/10.1097/ju.0000000000002190.